Company profile: Valo Health
1.1 - Company Overview
Company description
- Provider of AI-driven therapeutics discovery and development solutions leveraging large-scale human data. Offerings include the Opal computational platform to identify and validate drug targets and enable small-molecule discovery; Target Discovery using machine learning and biomarkers; Logica, an integrated solution with Charles River Laboratories; and OPL-0401, an investigational ROCK1/2 inhibitor for diabetic retinopathy.
Products and services
- Logica: An end-to-end AI-powered drug discovery product developed with Charles River Laboratories that transforms drug discovery from target identification to candidate nomination
- Opal Computational Platform: A large-scale AI-driven drug development engine that integrates human data to identify and validate novel targets, facilitating discovery and development of small molecule therapies
- Target Discovery: A human-data-derived system that utilizes machine learning to identify disease-associated targets and biomarkers, bypassing traditional models like cell or animal studies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Valo Health
Nucleai
HQ: United States
Website
- Description: Provider of an AI-powered spatial biology platform designed to enhance drug development and improve patient outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nucleai company profile →
Massive Bio
HQ: United States
Website
- Description: Provider of an AI-powered oncology platform that connects cancer patients to clinical trials and enables pharma to access patients. Offers SYNERGY-AI clinical trial matching, AskFiona and DrArturo AI chatbots, telehealth consultations, genomics analysis for personalized treatment, and concierge services to help patients navigate care and trial options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Massive Bio company profile →
Medable
HQ: United States
Website
- Description: Provider of a global decentralized clinical trial platform powered by patient-generated data that streamlines design, recruitment, retention, and data quality, replaces siloed systems with integrated digital tools, data, and interfaces to accelerate trial execution, and connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medable company profile →
Labstep
HQ: United Kingdom
Website
- Description: Provider of a data and inventory management platform that captures real-time scientific process data to create an internally shareable timeline of a lab's activity and connects notebooks, inventory, applications, and data in one collaborative workspace.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labstep company profile →
Trials.ai
HQ: United States
Website
- Description: Provider of an AI-powered Smart Protocol system that optimizes clinical trial protocols and guides research teams in designing trials for speed and success, helping pharma, biotech, and device companies get treatments to patients faster.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trials.ai company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Valo Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Valo Health
2.2 - Growth funds investing in similar companies to Valo Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Valo Health
4.2 - Public trading comparable groups for Valo Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →